Zoe Billinghurst/ LinkedIn
Jun 14, 2026, 15:51
Zoe Billinghurst: Strengthening the Global Rare Blood Disorders Community at EHA 2026
Zoe Billinghurst, Senior Global Brand Director of Rare Blood and Renal Disorders at Novo Nordisk, shared post on LinkedIn:
“Building insights about Rare Blood Disorders – global unmet needs, clinical practice, research advances – steps forward since EHA 2025.
Building on established collaborations and instigating new ones. Amazing and intense week in Stockholm at EHA 2026 with amazing colleagues from Novo Nordisk Rare Disease team.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn RuksakulpiwatÖ‰ A New Milestone in the Development of the Stroke Risk Screening Scales